biopharma

(8 search results)

Reliance's promising “off-balance sheet” item
Boost For India’s Generic Pharma Majors
Biocon shares rise 2% on deal with Sandoz
Concord Biotech shares list at 21% premium; surge up to 26% post debut
Biocon shares jump 7% on strong Q4, dividend declaration
Biocon stock tumbles 12% in 5 sessions; here’s why
Reimagining Indian pharma

Reimagining Indian pharma

Biocon’s biosimilar biz tops $4 bn in valuation